Successful use of telemedicine for the evaluation of infantile hemangiomas at the start of the COVID-19 pandemic


The use of telemedicine has rapidly increased due to the COVID-19 outbreak. In order to diagnose and treat infantile hemangiomas (IH), hemangioma experts have used telemedicine during the COVID-19 outbreak. For one study, researchers looked at experiences and perceived effectiveness of various treatment methods and any barriers related to childbirth.

From March to September 2020, a multicenter cross-sectional research asked healthcare professionals to explain their early HI assessments using telemedicine.

A total of 281 participants from 15 medical institutions around the world took part in the research. It took an average of 17 days from referral to assessment. The median level of physician confidence in performing telemedicine assessments was 95.0 (IQR 90.0–100.0). When images were not originally available, 51.4% of assessments were conducted by video communication with photographs or by voice communication with photographs. Service providers favored photographic monitoring methods.

Physicians with extensive experience in treating IH were confident in their ability to diagnose and treat IH using telemedicine, including starting treatment in patients with no risk factors for beta-blocker drugs. The use of hybrid modalities containing images was preferred. Evidence points to the potential of telemedicine to control HI and its potential to shorten waiting times and provide access to specialists in deprived areas.



Comments are closed.